Brief: Neximmune - On April 25, Got Letter From Nasdaq That Co Has 180-Day Extension To October 23 To Regain Compliance With Minimum Bid Price Requirement
26/04/2023 22:11
April 26 (Reuters) - Neximmune Inc NEXI.O :
* NEXIMMUNE - ON APRIL 25, GOT LETTER FROM NASDAQ THAT CO
HAS
180-DAY EXTENSION TO OCTOBER 23 TO REGAIN COMPLIANCE WITH
MINIMUM BID PRICE REQUIREMENT
Further company coverage: NEXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neximmune
See all newsBrief: Neximmune Appointed Albert Marchio As Interim CFO
Brief: NexImmune and Agents Agreed To Terminate Sales Agreement & ATM Program dated June 2022
Brief: NexImmune Says Co Expects Existing Cash And Cash Equivalents Will Be Sufficient To Meet Its Anticipated Cash Requirements Through Mid-February 2024
Brief: Neximmune Gets Notice From Listing Qualifications Department Of Nasdaq
Brief: NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting